Related Experiment Videos
Autologous blood transfusion for elective surgery
The Medical Journal of Australia
|April 14, 1986
Summary
This study found that autologous blood transfusion programs are feasible and safe for elderly patients undergoing surgery. An efficient service should complement, not replace, homologous blood transfusions.
Area of Science:
- Transfusion Medicine
- Surgical Patient Care
Background:
- Autologous blood transfusion (ABT) programs aim to reduce risks associated with homologous blood transfusions.
- Elderly patients present unique challenges for ABT due to potential comorbidities.
Purpose of the Study:
- To assess the feasibility and outcomes of an autologous blood transfusion program in a mixed surgical patient population, with a focus on elderly individuals.
- To determine the realistic upper limits and efficiency of an ABT service.
Main Methods:
- Retrospective analysis of 336 patients assessed by an Autologous Blood Transfusion Service between September 1983 and June 1985.
- Review of surgical and transfusion details for a one-month period.
- Evaluation of patient suitability for ABT, particularly in elective surgery cases requiring crossmatched blood.
Main Results:
- Orthopaedic and vascular surgery comprised 80% of cases.
- Complications were minor, even in the elderly patient group.
- For elective surgery cases requiring crossmatched blood, 45% were unsuitable as autologous donors, 21% had participated in the program, and 34% were suitable.
- The realistic upper limit for ABT in elective cases requiring crossmatched blood was determined to be 55%.
Conclusions:
- Autologous blood transfusion programs are safe and feasible, even for elderly surgical patients.
- An efficient ABT service should be integrated with homologous blood transfusion services and act as a complement, not a replacement.
- The study highlights the importance of careful donor selection and program integration for optimal outcomes.